MOUNTAINEER-02: Phase II/III study of tucatinib, trastuzumab, ramucirumab, and paclitaxel in previously treated HER2+ gastric or gastroesophageal junction adenocarcinoma - Trial in Progress Meeting Abstract
| Authors: | Strickler, J. H.; Nakamura, Y.; Yoshino, T.; Catenacci, D. V. T.; Janjigian, Y. Y.; Barzi, A.; Bekaii-Saab, T. S.; Lenz, H. J.; Lee, J.; Van Cutsem, E.; Chung, H. C.; Alsina, M.; Siena, S.; Mayor, J. G.; Palanca-Wessels, M. C.; Feng, W.; Marshall, J. |
| Abstract Title: | MOUNTAINEER-02: Phase II/III study of tucatinib, trastuzumab, ramucirumab, and paclitaxel in previously treated HER2+ gastric or gastroesophageal junction adenocarcinoma - Trial in Progress |
| Meeting Title: | 2021 Gastrointestinal Cancers Symposium (ASCO GI) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 39 |
| Issue: | 3 Suppl. |
| Meeting Dates: | 2021 Jan 15-17 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2021-01-20 |
| Language: | English |
| ACCESSION: | WOS:000636712800020 |
| DOI: | 10.1200/JCO.2021.39.3_suppl.TPS252 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: TPS252 -- Source: Wos |
